All Research on Oncology in Europe

Insight

Report
Report

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research.

Published By Datamonitor
$7500
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
$2000
Buy
Report
Report

Pipeline: Colorectal Cancer

Developers look to other molecular targets to avoid direct competition

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Interactive Model
Interactive Model

Medtrack: Cancer Pipeline Databook - May 2013

This in-depth Excel databook covers the cancer pipeline by company and phase.

Published By Datamonitor
$2900
Buy
Interactive Model
Interactive Model

The Prostate Cancer Market Forecast to 2021

Recent approvals reinvigorate mCRPC market

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

Market Forecasts: Non-Small Cell Lung Cancer

There are 700,000 new cases of lung cancer each year and NSCLC constitutes about 80% of the total lung cancer patient population. Pharma have been attracted by the high incidence of this disease and the NSCLC pipeline has grown substantially.

Published By Datamonitor
$6400
Buy

Profiles

Company Profile
Company Profile

Bayer AG

Bayer (or 'the group') is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, Germany, and employed about 118,900 people as on December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Bayer Healthcare Pharmaceuticals

Bayer HealthCare Pharmaceuticals (Bayer Pharma or 'the company'), a business division of Bayer, primarily focuses on the development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women's healthcare. It operates in Europe, the Americas, Asia Pacific, Africa and Middle East. The company is headquartered in Berlin, Germany and employed about 39,000 people as on December 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Sandoz International GmbH

Sandoz International (Sandoz or 'the company'), the generic business division of Novartis, is engaged in the development, manufacture and marketing of generic medicines as well as pharmaceutical and biotechnological active ingredients. Sandoz has its presence in the US, Europe, Asia, Africa, Australasia, Canada and Latin America. The company is headquartered in Holzkirchen, Germany, and employed 26,423 people as of December 31, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.